A prospective Phase II trial to evaluate the efficacy and toxicity of hepatic arterial infusion of ifosfamide in patients with inoperable localized hepatocellular carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 20, Issue 3, 1997, Pages 289-292

  Malik, Imtiaz A ^a   Khan, Wajahat A ^a   Haq, Saba ^a   Sabih, Mehreen ^a  

^a National Cancer Institute   (Pakistan)

Author keywords

Chemotherapy; Hepatic arterial infusion; Hepatocellular cancer; Ifosfamide; Inoperable cancer

Indexed keywords

ALPHA FETOPROTEIN; HEPARIN; IFOSFAMIDE; INFUSION FLUID; MESNA; SODIUM CHLORIDE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CATHETER INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DRUG EFFICACY; DRUG TOLERABILITY; ECHOGRAPHY; HEPATIC ARTERY; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; VIRUS HEPATITIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CARCINOMA, HEPATOCELLULAR; HUMANS; IFOSFAMIDE; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL ANALYSIS;

EID: 0030905333     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199706000-00017     Document Type: Article

References (24)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 18 major cancers in 1985. Int J Cancer 1993;54: 594-606.
2. Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J, eds. Cancer Incidence in Five Continents. Volume VI (IARC Scientific publication No. 120). Lyon: IARC, 1992.
3. Rustgi V. Epidemiology of hepatocellular carcinoma. Ann Intern Med 1988;108:390-401.
4. Okuda K, Ohtsuki T, Obata H, Tomimatu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985;56:918-28.
5. Nagao T, Goto S, Kawano N, et al. Hepatic resection for hepatocellular carcinoma: clinical features and long term prognosis. Ann Surg 1987;205:33-40.
6. Ottow RT, August DA, Sugerbaker PH. Surgical therapy of liver cancer. In: Bottino JC, Opfell RN, Muggia FM, eds. Liver cancer. Boston: Martinus Nijhoff, 1985;99-142.
7. Okuda K, Obata H, Nakajima Y, et al. Prognosis of primary hepato-cellular carcinoma. Hepatology 1984;4:35-65.
8. Colombo M. Hepatocellular carcinoma. J Hepatol 1992; 15: 225-36.
9. Khurshid H, Malik I. Recent advances in etiology, pathogenesis and management of hepatocellular cancer. JPMA 1995;45: 136-43.
10. Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994;219(3):236-47.
11. Falkson G, Macintyre J, Moertel C, et al. Primary liver cancer: an Eastern Cooperative Oncology Group Trial. Cancer 1984;54:970-7.
12. Falkson G, Rayan LM, Johnson LA, et al. A randomized phase II study of mitrozantrone and cisplatin in patients with hepatocellular carcinoma: an ECOG study. Cancer 1987;60:2141-5.
13. Ravry JR, Omura GA, Bartolucci AA. Phase II evaluation of doxorubicin plus bleomycin in hepatocellular carcinoma: a South Eastern Cancer Study Group Trial. Cancer Treat Rep 1984;68:1517-8.
14. Scarrino E, Simonetti R, Le Moli S, et al. Adriamycin treatment for hepatocellular carcinoma: experience with 109 patients. Cancer 1985;56:2751-4.
15. Ramming KP. The effectiveness of hepatic artery infusion in treatment of primary hepatobiliary tumors. Semin Oncol 1983;10:199-205.
16. Novell JR, Dusheiko G, Markham NI, et al. Selective regional chemotherapy of unresectable hepatic tumor using Lipoidol. J Hepatic Pancreatic Biliary Surg 1991;4:223-36.
17. Nakamura K, Takashima S, Takada K, et al. Clinical evaluation of intermittent arterial infusion chemotherapy with an implanted reservoir for hepatocellular carcinoma. Cancer Chemother Pharmacol 1992;31(suppl 1):S93-S98.
18. Thongprasert S, Klunklin K, Phornphutkul K, et al. A phase II study of ifosfamide in hepatoma. Eur J Cancer Clin Oncol 1988;24:1795-6.
19. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
20. Falkson G, Cnaan A, Schutt AJ, et al. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 1988;48: 7314-8.
21. Ohuishi K, Suqita S, Nomura F, et al. Arterial chemoembolization with mitomycin microcapsules followed by transcatheter hepatic artery embolization for HCC. Am J Gastroenterol 1987:82:876-9.
22. Konno T, Maeda H, Iwai K, et al. Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast media. Cancer 1984;54:2364-7.
23. Kanemtsu J, Furuta J, Takenaka K, et al. A five year experience of lipoidolization: selective regional chemotherapy for 200 patients with hepatoma. Hepatology 1989; 10:98-102.
24. Fruta T, Kanamatsu T, Matsumata T, et al. Lipoidolization prolongs survival rates in post operative patients with recurrent hepatoma. Hepatogastroenterology 1990;37:494-7.